Morepen Labs.

{
  "main_header": {
    "sid": 546345,
    "name": "Morepen Labs.",
    "stock_name": "Morepen Labs.",
    "full_name": "Morepen Laboratories Ltd",
    "name_url": "stocks-analysis/morepen-labs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "36.99",
    "chg": -0.05,
    "chgp": "-0.13%",
    "dir": -1,
    "prev_price": "37.04",
    "mcapval": "2,066.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500288,
    "symbol": "MOREPENLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE083A01026",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": "26.84 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/morepen-labs-546345-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Morepen Laboratories Ltd Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-technical-momentum-shifts-amid-bearish-signals-3895656",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MorepenLaborato_technicaldot_3895656.png",
        "date": "2026-03-17 08:02:00",
        "description": "Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Despite some mildly bullish weekly indicators, the overall technical landscape suggests caution for investors as key momentum indicators and moving averages signal downward pressure on the stock price."
      },
      {
        "title": "Morepen Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/morepen-laboratories-ltd-is-rated-sell-3892116",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MorepenLaborato_mojoScore_3892116.png",
        "date": "2026-03-15 10:10:23",
        "description": "Morepen Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date perspective on the company's performance and outlook."
      },
      {
        "title": "Morepen Laboratories Ltd Valuation Shifts to Fair Amid Sector Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-valuation-shifts-to-fair-amid-sector-volatility-3878772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MorepenLaborato_valuationdot_3878772.png",
        "date": "2026-03-09 08:00:30",
        "description": "Morepen Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, signalling a potential recalibration of investor sentiment in the Pharmaceuticals & Biotechnology sector. Despite recent price declines, the stock’s valuation metrics now present a more attractive entry point relative to its historical averages and peer group."
      },
      {
        "title": "Morepen Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/morepen-laboratories-ltd-is-rated-sell-3868901",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MorepenLaborato_mojoScore_3868901.png",
        "date": "2026-03-04 10:10:34",
        "description": "Morepen Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Morepen Laboratories Ltd Opens with Significant Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-opens-with-significant-gap-down-amid-market-concerns-3863797",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MorepenLaborato_gapdown_3863797.png",
        "date": "2026-03-02 09:32:40",
        "description": "Morepen Laboratories Ltd experienced a sharp gap down at market open today, reflecting heightened market concerns and a volatile trading session. The stock opened 8.61% lower, continuing a recent downward trend amid mixed technical signals and sector pressures."
      },
      {
        "title": "Morepen Laboratories Gains 11.37%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-gains-1137-5-key-factors-driving-the-weeks-momentum-3862589",
        "imagepath": "",
        "date": "2026-02-28 16:03:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Feb:</strong> Intraday high surge of 15.55% with exceptional volume</p>\n                    <p><strong>23 Feb:</strong> Strong gap-up opening signalling positive market sentiment</p>\n                    <p><strong>24 Feb:</strong> Exceptional volume surge amid continued price gains</p>\n                    <p><strong>24 Feb:</strong> Valuation shifts from fair to expensive on rising multiples</p>\n                    <p><strong>26 Feb:</strong> Modest price recovery after a dip on 25 Feb</p>\n                    <p><strong>27 Feb:</strong> Week closes at Rs.43.78, outperforming Sensex by 12.33%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                   ..."
      },
      {
        "title": "Morepen Laboratories Sees Exceptional Volume Surge Amid Strong Price Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-sees-exceptional-volume-surge-amid-strong-price-gains-3852751",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MorepenLaborato_most_active_equities_by_volume_3852751.png",
        "date": "2026-02-24 10:00:14",
        "description": "Morepen Laboratories Ltd (MOREPENLAB), a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a remarkable surge in trading volume, signalling heightened investor interest and a potential shift in market sentiment. The stock outperformed its sector and broader indices, driven by strong accumulation signals and sustained price gains over recent sessions."
      },
      {
        "title": "Morepen Laboratories Ltd Valuation Shifts Amidst Market Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-valuation-shifts-amidst-market-rally-3851966",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MorepenLaborato_valuationdot_3851966.png",
        "date": "2026-02-24 08:01:19",
        "description": "Morepen Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from a fair to an expensive rating, raising questions about its price attractiveness amid a volatile pharmaceutical sector. Despite a recent surge in share price, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest investors should carefully weigh growth prospects against valuation risks."
      },
      {
        "title": "Morepen Laboratories Surges on Exceptional Volume Amid Renewed Investor Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-surges-on-exceptional-volume-amid-renewed-investor-interest-3851302",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MorepenLaborato_most_active_equities_by_volume_3851302.png",
        "date": "2026-02-23 10:00:19",
        "description": "Morepen Laboratories Ltd (MOREPENLAB) emerged as one of the most actively traded stocks on 23 Feb 2026, registering a remarkable surge in volume and price amid a backdrop of mixed technical and fundamental signals. The pharmaceutical small-cap witnessed a 13.18% gain on the day, driven by heightened investor participation and a notable gap-up opening, yet retains a cautious outlook from rating agencies."
      }
    ],
    "total": 389,
    "sid": "546345",
    "stock_news_url": "https://www.marketsmojo.com/news/morepen-laboratories-546345"
  },
  "announcements": [
    {
      "details": "Morepen Laboratories Limited has informed the Exchange regarding Board meeting held on November 13, 2019.",
      "source": "NSE",
      "caption": "Morepen Laboratories Limited - Outcome of Board Meeting",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Morepen Laboratories Limited has informed the Exchange regarding 'Order Passed by SEBI'.",
      "source": "NSE",
      "caption": "Morepen Laboratories Limited - Updates",
      "datetime": "25-Sep-2019"
    },
    {
      "details": " <table><tr><td>Morepen Laboratories Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on October 19, 2019 </td></tr></table>",
      "source": "NSE",
      "caption": "Shareholders meeting",
      "datetime": "24-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Morepen Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 29 Aug 25",
          "dt": "2025-08-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Morepen Laboratories Ltd Technical Momentum Shifts Amid Bearish Signals

2026-03-17 08:02:00

Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Despite some mildly bullish weekly indicators, the overall technical landscape suggests caution for investors as key momentum indicators and moving averages signal downward pressure on the stock price.

Read full news article

Morepen Laboratories Ltd is Rated Sell

2026-03-15 10:10:23

Morepen Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date perspective on the company's performance and outlook.

Read full news article

Morepen Laboratories Ltd Valuation Shifts to Fair Amid Sector Volatility

2026-03-09 08:00:30

Morepen Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, signalling a potential recalibration of investor sentiment in the Pharmaceuticals & Biotechnology sector. Despite recent price declines, the stock’s valuation metrics now present a more attractive entry point relative to its historical averages and peer group.

Read full news article

Morepen Laboratories Ltd is Rated Sell

2026-03-04 10:10:34

Morepen Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Morepen Laboratories Ltd Opens with Significant Gap Down Amid Market Concerns

2026-03-02 09:32:40

Morepen Laboratories Ltd experienced a sharp gap down at market open today, reflecting heightened market concerns and a volatile trading session. The stock opened 8.61% lower, continuing a recent downward trend amid mixed technical signals and sector pressures.

Read full news article

Morepen Laboratories Gains 11.37%: 5 Key Factors Driving the Week’s Momentum

2026-02-28 16:03:31

Key Events This Week

23 Feb: Intraday high surge of 15.55% with exceptional volume

23 Feb: Strong gap-up opening signalling positive market sentiment

24 Feb: Exceptional volume surge amid continued price gains

24 Feb: Valuation shifts from fair to expensive on rising multiples

26 Feb: Modest price recovery after a dip on 25 Feb

27 Feb: Week closes at Rs.43.78, outperforming Sensex by 12.33%

...

Read full news article

Morepen Laboratories Sees Exceptional Volume Surge Amid Strong Price Gains

2026-02-24 10:00:14

Morepen Laboratories Ltd (MOREPENLAB), a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a remarkable surge in trading volume, signalling heightened investor interest and a potential shift in market sentiment. The stock outperformed its sector and broader indices, driven by strong accumulation signals and sustained price gains over recent sessions.

Read full news article

Morepen Laboratories Ltd Valuation Shifts Amidst Market Rally

2026-02-24 08:01:19

Morepen Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from a fair to an expensive rating, raising questions about its price attractiveness amid a volatile pharmaceutical sector. Despite a recent surge in share price, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest investors should carefully weigh growth prospects against valuation risks.

Read full news article

Morepen Laboratories Surges on Exceptional Volume Amid Renewed Investor Interest

2026-02-23 10:00:19

Morepen Laboratories Ltd (MOREPENLAB) emerged as one of the most actively traded stocks on 23 Feb 2026, registering a remarkable surge in volume and price amid a backdrop of mixed technical and fundamental signals. The pharmaceutical small-cap witnessed a 13.18% gain on the day, driven by heightened investor participation and a notable gap-up opening, yet retains a cautious outlook from rating agencies.

Read full news article

View All News